oa Southern African Journal of Gynaecological Oncology - Pemetrexed approved for use in first-line treatment of most common lung cancer : press release

Volume 1, Issue 2
  • ISSN : 2074-2835
  • E-ISSN: 2220-105X



Lilly today announced that their pemetrexed for injection has been approved for a histologically-based use in the first-line treatment of advanced non-small-cell lung cancer (NSCLC), the most common form of lung cancer.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error